Acute Lymphoblastic Leukemia Therapy
Reports from University Hospital, Department of Hematology advance knowledge in acute lymphoblastic leukemia therapy
Published in Hospital and Nursing Home Week, May 31st, 2007
Research findings, "Imatinib compared with chemotherapy as front-line treatment of elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL)," are discussed in a new report. "Elderly patients with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ALL) have a poor prognosis, with a low complete remission (CR) rate, high induction mortality, and short remission duration. Imatinib (IM) has a favorable toxicity profile but limited antileukemic activity in advanced Ph+ALL," investigators in Germany report.
"Imatinib in combination with intensive chemotherapy has yielded promising results as front-line therapy, but its value...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital and Nursing Home Week
More Articles from Hospital and Nursing Home Week
- Acute Lymphoblastic Leukemia Therapy
Data on acute lymphoblastic leukemia therapy detailed by researchers at La Sapienza University - Acute Myeloid Leukemia Therapy
Studies from Erasmus University, Department of Hematology reveal new findings on acute myeloid leukemia therapy - AdCare Health Systems, Inc.
AdCare Health Systems, Inc. Reports 2007 First Quarter Earnings Results - Adenoma
Researchers from West Virginia University, Department of Surgery report on findings in adenoma - Adverse Drug Reactions
Research from Massachusetts General Hospital in adverse drug reactions provides new insights - Aging
The Age Wave Is Coming and Will Cost California Businesses Billions in Lost Productivity - More from this issue of Hospital and Nursing Home Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
